会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • COMPOSITION CONTAINING HEMATOPOIESIS INHIBITOR
    • 抑制剂DU BLUTBILDUNG ENTHALTENDE ZUSAMMENSETZUNG。
    • EP0648782A1
    • 1995-04-19
    • EP94901037.5
    • 1993-12-03
    • TORAY INDUSTRIES, INC.
    • YAMADA, Tomoko 8-105, Wakatake-cho 8-chomeKATAOKA, Hiroshi 15-1, Sonoyama 2-chome
    • C07K15/06C07K1/00C07K3/18A61M1/16A61M1/34A61K38/00A61K35/16
    • C07K14/47A61K38/00C07K14/52
    • A composition containing a hematopoiesis inhibitor that inhibits CFU-E colony formation and comprising a substance present in the filtrate obtained by concentrating a dialyzate, obtained by dialyzing blood through a dialysis membrane having an albumin sieving coefficient of 0.01 or above, with a membrane having a fractionating molecular weight of 5,000 or less and then filtering the concentrate with a gel having a maximum fractionating molecular weight ranging from 0.2 to 1.5 million. The invention also relates to a method of treating blood characterized by removing an A I component so as to satisfy the following relationship: A I /A A ≧ 1/50 wherein A I represents the height of the absorbance value of a composition containing a hematopoiesis inhibitor, as set forth in any of claims 1 through 5, at a wavelength of 280 nm in the gel filtration pattern of the solute in the dialyzate, and A A represents the height of the maximum absorbance value in the gel filtration pattern. The invention further relates to a dialysis membrane characterised in that the following relationship holds: A I /A A ≧ 1/50 wherein A I , represents the height of the absorbance value of a composition containing a hematopoiesis inhibitor, as set forth in any of claims 1 through 5, at a wavelength of 280 nm in the gel filtration pattern of the solute in the dialyzate, and A A represents the height of the maximum absorbance value in the gel filtration pattern. In addition, the invention relates to a pharmaceutical composition and an erythrocytosis remedy each containing the hematopoiesis inhibitor.
    • 一种含有抑制CFU-E集落形成的造血抑制剂的组合物,其含有通过浓缩透析液获得的滤液中存在的物质,所述透析液是通过使透过透析膜的蛋白质筛分系数为0.01以上的血液透析得到的, 分级分子量为5,000或更小,然后用最大分馏分子量范围为0.2-1.5百万的凝胶过滤浓缩物。 本发明还涉及一种治疗血液的方法,其特征在于除去AI成分以满足以下关系:AI / AA> / = 1/50其中,AI表示含有造血抑制剂的组合物的吸光度值的高度, 权利要求1〜5中任一项所述的透析液中的溶质的凝胶过滤图案中的波长为280nm,AA表示凝胶过滤图案中的最大吸光度值的高度。 本发明还涉及一种透析膜,其特征在于以下关系成立:AI / AA> / = 1/50其中,AI代表含有造血抑制剂的组合物的吸光度值的高度,如权利要求 1〜5,透析液中溶质的凝胶过滤图案中波长280nm,AA表示凝胶过滤图案中最大吸光度值的高度。 此外,本发明涉及每种含有造血抑制剂的药物组合物和红细胞增多症药物。